Two investment firms have acquired large stakes in global CRO Novotech, the Singapore-based company announced March 30. GIC ...
The two sovereign wealth funds have taken a “significant stake” in the clinical research business owned by the private equity ...
Existing investor TPG will also reinvest through its TPG Asia fund. Novotech, headquartered in Singapore with a global presence across more than 30 offices, is one of the world’s leading full ...
The reinvestment by TPG Asia and investment from GIC and Temasek will allow Novotech to pursue further organic growth and ...
SINGAPORE] Clinical research and testing provider Novotech on Monday (Mar 31) announced that Temasek and GIC will acquire a ...
Since TPG’s investment in 2017, the firm has raised its headcount tenfold to 3,000 employees and expanded its operations ...
LionRock’s investments in the rest of the world (outside the U.S. and India) have expanded to over 25%, largely at the ...
1 天
Singapore Business Review on MSNGIC, Temasek to acquire ‘significant stake’ in biotech CRO NovotechNovotech provides biotech to small and mid-sized pharma companies. GIC and Temasek have signed a binding agreement to acquire “a significant stake” in Novotech, a biotech specialist clinical research ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果